Dublin, April 30, 2019 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics/Testing Market Size, Share & Trends Analysis Report by Product (Glucose, Blood Gas/Electrolytes, Cancer Marker), By End Use (Clinic, Hospital), And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global point of care testing market size is expected to reach USD 22.8 billion by 2025, at a CAGR of 3.3%
The ability of Point of Care (POC) tests to render rapid and accurate results to promote patient-centered healthcare at bedside settings as well as in the remote areas results in higher penetration of POC devices and solutions.
Adaptation of automated laboratory systems and highly integrated solutions facilitate the diagnostic workflow, which in turn drives adoption of point of care diagnostic/testing products. Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these devices.
Rise in R&D activities among key players to introduce novel POC tests and devices for rapid disease detection and monitoring is expected to fuel industrial progression. Recently, in February 2018, Siemens Healthineers received a Food and Drug Administration (FDA) approval for its Total Carbon Dioxide (TCO2) and Blood Urea Nitrogen (BUN) POC tests, thereby enhancing its market presence.
Moreover, high prevalence of chronic disorders and cancer results in large customer base adopting cost-effective and immediate diagnostic tests, propelling the point of care diagnostics/testing market. This is further supplemented by numerous favorable initiatives to promote the employment of POC tests in diagnosis and screening procedures.
Further key findings from the report suggest:
- Glucose testing held the maximum revenue share in 2018 due to high prevalence of diabetes and introduction of a wide variety of glucose meters by companies
- Hb1Ac testing segment is also expected to show similar trends owing to high competition among key players while delivering low-cost Hb1Ac tests
- Detection and analysis of circulating tumor cells during cancer progression is predicted to drive the cancer marker vertical with the fastest penetration rate in the forthcoming years
- Clinics is estimated to hold the dominant revenue share of the POC diagnostic industry in 2018, due to the employment of a wide range of POC tests
- Increasing awareness about decentralized tests among patients has resulted in lucrative growth of home-based POC testing
- U.S. is anticipated to North America owing to the presence of key participants with undergoing significant number of research endeavors in the country
- Continuous developments in healthcare sector to introduce novel and accurate diagnostic tests exhibit a potential growth of the market in Asia Pacific
- Major participants in the point of care diagnostics market include F. Hoffmann-La Roche Ltd.; Danaher Corporation; Abbott Laboratories; bioMrieux SA; Instrumentation Laboratory SpA; Nova Biomedical; Trividia Health, Inc.; QIAGEN; Becton Dickinson & Company; Sekisui Diagnostics LLC; Quidel Corporation; and Siemens Healthcare GmbH
- Key vendors are undergoing numerous strategic developments such as product development, acquisitions, partnerships, and agreements to gain greater market share. For instance, in May 2017, Becton, Dickinson and Company collaborated with the FIND to develop point of care based biomarker test for bacterial infections.
Key Topics Covered:
Chapter 1 Research Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Point of Care Diagnostics/Testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping, 2018
3.3 Product positioning analysis
3.4 Price-cost-margin analysis for point-of-care devices
3.5 User Perspective Analysis
3.5.1. Consumer behavior analysis
3.5.2. Market influencer analysis
3.6 List of Key End-users By Region, By Product, By Country
3.7 Technology Overview
3.7.1. Technology timeline
3.8 Regulatory Framework
3.8.1. Reimbursement framework
3.8.2. Standards & compliances
3.9 Point of Care Diagnostics/Testing Market - Market Dynamics
3.9.1 Market driver analysis
3.9.1.1 Introduction of CLIA waived tests
3.9.1.2 Increasing adoption of POC diagnostics
3.9.1.3 Growing demand for home healthcare and the introduction of advance technology enabled products
3.9.1.4 Growing geriatric population base
3.9.1.5 Growing prevalence of target diseases
3.9.2 Market restraint analysis
3.9.2.1 High procedure costs
3.9.2.2 Presence of ambiguous regulatory framework
3.9.3 Market challenges analysis
3.9.3.1 POC devices pose challenges in maintaining the quality standards
3.10 Point of Care Diagnostics/Testing Market Analysis Tools
3.10.1 Industry Analysis - Porter's
3.11.1.1 Supplier power : Large scale raw material suppliers results in moderate bargaining supplier power
3.11.1.2 Buyer power: High bargaing power of buyer due to increased demand of POC devices
3.11.1.3 Substitution threat: Low substitution threat owing to the lacking replacement for POC procedures
3.11.1.4 New entrants threat: Low new entrant threat owing to large scale investment for POC set up
3.11.1.5 Competitive rivalry: High capitalization due to product launches led to high competitive rivalry
3.10.2 PESTEL analysis
3.10.3 Major deals & strategic alliances analysis
3.10.4 Market entry strategies
3.10.5 Case studies
Chapter 4 Point of Care Diagnostics/Testing Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 Key customers
4.3.2 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market share/ranking by region
4.4.3 Competitive dashboard analysis
4.4.4 Market differentiators
4.4.5 Synergy analysis: Major deals & strategic alliances
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Funding outlook
4.5.3 Regional network map
4.5.4 Company market position analysis
4.5.5 Supplier Ranking
Chapter 5 Point of Care Diagnostics/Testing Market: Product Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Product Market Share Analysis, 2018 & 2025
5.3 Point of Care Diagnostics/Testing Market: Product Movement Analysis, 2018 & 2025
5.4. Global Point of Care Diagnostics/Testing Market, by Product, 2014 to 2025
5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
5.5.1 Glucose testing
5.5.2 Hb1Ac testing
5.5.3 Coagulation testing
5.5.4 Fertility testing
5.5.5 Cardiac markers
5.5.6 Infectious disease testing
5.5.6.1 Infectious disease testing market, 2014 - 2025 (USD Million)
5.5.6.2 HIV POC testing
5.5.6.3 Clostridium Difficile POC testing
5.5.6.4 HBV POC testing
5.5.6.5 Pneumonia or streptococcus associated infections
5.5.6.6 Respiratory Syncytial Virus (RSV) POC testing
5.5.6.7 HPV POC testing
5.5.6.8 Influenza/flu POC testing
5.5.6.9 HCV POC testing
5.5.6.10 MRSA POC testing
5.5.6.11 TB and drug-resistant TB POC
5.5.6.13 Other infectious diseases POC testing
5.5.7 Primary care systems
5.5.8 Hematology testing
5.5.9 Decentralized clinical chemistry
5.5.10 Blood gas/electrolytes testing
5.5.11 Ambulatory chemistry
5.5.12 Urinalysis
5.5.13 Drug abuse testing
5.5.14 Thyroid stimulating hormone
5.5.15 Feces testing
5.5.16 Lipid testing
5.5.17 Cancer marker testing
5.6 Point of Care Diagnostics/Testing Product Market, by End Use, 2014 to 2025
Chapter 6 Point of Care Diagnostics/Testing Market: End Use Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. End Use Market Share Analysis, 2018 & 2025
6.3 Point of Care Diagnostics/Testing Market: End Use Movement Analysis, 2018 & 2025
6.4. Global Point of Care Diagnostics/Testing Market, by End Use, 2014 to 2025
6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
6.5.1 Clinics
6.5.1.1 Clinics market, 2014 - 2025 (USD Million)
6.5.1.2 Pharmacy & retail clinics
6.5.1.3 Physician office
6.5.1.4 Urgent care clinics
6.5.1.5 Non-practice clinics
6.5.2 Hospitals
6.5.3 Home
6.5.4 Assisted Living Healthcare Facilities
6.5.5 Laboratories
6.5.6 Others
Chapter 7 Point of Care Diagnostics/Testing Market: Regional Estimates & Trend Analysis, by Product, & End Use
7.1 Point of Care Diagnostics/Testing Market Share by Region, 2018 & 2025
7.2 Regional Market Share and Leading Players, 2018
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
Companies Featured
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthcare GmBH
- Danaher Corporation
- bioMerieux SA
- Abaxis, Inc.
- Becton Dickinson & Company
- Qiagen N.V.
- Spectral Diagnostics
- Instrumentation Laboratory SpA
- Johnson and Johnson
- Nova Biomedical
- Nipro Diagnostics Inc
- HemoCue AB
- International Technidyne Corporation (ITC)
- Quidel Corporation
- Trinity Biotech PLC
- Sekisui Diagnostics LLC
- OraSure Technologies Inc
For more information about this report visit https://www.researchandmarkets.com/r/wtsf20
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.